Literature DB >> 31076978

Scleroderma renal crisis: a review for emergency physicians.

Tim Montrief1, Alex Koyfman2, Brit Long3.   

Abstract

Scleroderma renal crisis (SRC) remains a high-risk clinical presentation, and many patients require emergency department (ED) management for complications and stabilization. This narrative review provides an evidence-based summary of the current data for the emergency medicine evaluation and management of SRC. While SRC remains a rare clinical presentation, surveillance data suggest an overall incidence between 4 and 6% of patients with scleroderma. The diagnostic criteria for SRC include a new onset blood pressure > 150/85 mm Hg OR increase ≥ 20 mm Hg from baseline systolic blood pressure, along with a decline in renal function, defined as an increase serum creatinine of ≥ 10% and supportive features. There are many risk factors for SRC, including diffuse and rapidly progressive skin thickening, palpable tendon friction rubs, and new anemia or cardiac events. Critical patients should be evaluated in the resuscitation bay, and consultation with the nephrology team for appropriate patients improves patient outcomes.

Entities:  

Keywords:  Nephrology; Renal; Scleroderma

Mesh:

Substances:

Year:  2019        PMID: 31076978     DOI: 10.1007/s11739-019-02096-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  80 in total

1.  Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade.

Authors:  Winson Y Cheung; Ian W Gibson; David Rush; John Jeffery; Martin Karpinski
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

2.  Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature.

Authors:  Phuong-Thu T Pham; Phuong-Chi T Pham; Gabriel M Danovitch; H Albin Gritsch; Jennifer Singer; William D Wallace; Rick Hayashi; Alan H Wilkinson
Journal:  Am J Transplant       Date:  2005-10       Impact factor: 8.086

3.  Captopril in the treatment of scleroderma renal crisis.

Authors:  R H Thurm; J C Alexander
Journal:  Arch Intern Med       Date:  1984-04

Review 4.  Assessment of kidney involvement.

Authors:  V D Steen; M D Mayes; P A Merkel
Journal:  Clin Exp Rheumatol       Date:  2003       Impact factor: 4.473

Review 5.  Renal complications and scleroderma renal crisis.

Authors:  C P Denton; G Lapadula; L Mouthon; U Müller-Ladner
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

6.  Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.

Authors:  L Teixeira; L Mouthon; A Mahr; A Berezné; C Agard; M Mehrenberger; L-H Noël; P Trolliet; C Frances; J Cabane; L Guillevin
Journal:  Ann Rheum Dis       Date:  2007-06-08       Impact factor: 19.103

7.  Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.

Authors:  Y M Traub; A P Shapiro; G P Rodnan; T A Medsger; R H McDonald; V D Steen; T A Osial; S F Tolchin
Journal:  Medicine (Baltimore)       Date:  1983-11       Impact factor: 1.889

8.  Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis.

Authors:  S Akimoto; O Ishikawa; T Tamura; Y Miyachi
Journal:  Br J Dermatol       Date:  1996-03       Impact factor: 9.302

Review 9.  Scleroderma renal crisis.

Authors:  Luc Mouthon; Guillaume Bussone; Alice Berezné; Laure-Hélène Noël; Loïc Guillevin
Journal:  J Rheumatol       Date:  2014-05-15       Impact factor: 4.666

10.  Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis.

Authors:  J F Molina; J M Anaya; G E Cabrera; E Hoffman; L R Espinoza
Journal:  J Rheumatol       Date:  1995-03       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.